Teclistamab, an off-the-shelf (ready to use) subcutaneously administered therapy, induced deep and rapid responses in triple-class exposed patients with relapsed
Read more
Teva Pharmaceuticals is pleased to announce the launch of Fingolimod Teva, a generic high tech prescription medication indicated for multiple
Read more
Teva Pharmaceuticals is pleased to announce the launch of Varenicline Teva, a generic prescription medication indicated for smoking cessation. Varenicline
Read more
Clonmel Healthcare are delighted to announce the introduction of Uzpruvo®, the new Ustekinumab biosimilar. Uzpruvo® will be marketed from July
Read more
Janssen, the Pharmaceutical Companies of Johnson & Johnson, announced today that Darzalex ®(daratumumab) in combination with lenalidomide and dexamethasone (DRd)
Read more
IRELAND’S HSE APPROVES LILLY’S ABEMACICLIB IN COMBINATION WITH ENDOCRINE THERAPY FOR ADJUVANT TREATMENT OF PEOPLE WITH HR+, HER2- EARLY BREAST
Read more
AbbVie has announced that the Irish health authorities have approved reimbursement of PRODUODOPA® (foslevodopa/foscarbidopa) for the treatment of advanced levodopa-responsive
Read more
End-of-trial data show 79.7% efficacy in participants aged 50 years and over during long-term follow-up, six to 11 years after
Read more
Eli Lilly and Company announced that the European Commission (EC) granted marketing authorization (MA) on 19 April 2024 for tirzepatide
Read more
Following a 30-year joint venture, Sandoz, the world’s largest generics and biosimilars company, has acquired full ownership of Rowex. Rowex
Read more